Metraipolis › archive › dc_720b59265d4c
Phenol and Phthalate Effects on Thyroid Hormone Levels during Pregnancy: Relying on In Vitro Assays and Adverse Outcome Pathways to Inform an Epidemiological… — Europe PMC PMID:36350136
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/36350136
- DOI
- 10.1289/ehp10239
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-15T17:42:03.913Z
- SHA-256 of the archived text
bee6924d58f2ba0de0f7d5853601d74fa21ee4e5c241cec2381f65b22b05fdcf- Stable URL of this page
https://metraipolis.com/documento/dc_720b59265d4c
How to cite
Phenol and Phthalate Effects on Thyroid Hormone Levels during Pregnancy: Relying on In Vitro Assays and Adverse Outcome Pathways to Inform an Epidemiological… — Europe PMC PMID:36350136 — Europe PMC (en), https://europepmc.org/article/MED/36350136 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_720b59265d4c (Metraipolis archive dc_720b59265d4c, sha256 bee6924d58f2ba0de0f7d5853601d74fa21ee4e5c241cec2381f65b22b05fdcf)
BibTeX
@misc{dc720b59265d4c,
title = {Phenol and Phthalate Effects on Thyroid Hormone Levels during Pregnancy: Relying on In Vitro Assays and Adverse Outcome Pathways to Inform an Epidemiological… — Europe PMC PMID:36350136},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/36350136},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_720b59265d4c; sha256 bee6924d58f2ba0de0f7d5853601d74fa21ee4e5c241cec2381f65b22b05fdcf},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/36350136. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: Studies characterizing associations between phenols, phthalates and thyroid hormones during pregnancy produce inconsistent results. This divergence may be partly attributable to false positives due to multiple comparison testing of large numbers of chemicals, and measurement error as studies rely on small numbers of biospecimens despite high intra-individual variability in urinary chemical metabolite concentrations. Objectives: This study employs a priori chemical filtering and expanded urinary biomonitoring to evaluate associations between phenol/phthalate exposures and serum thyroid hormones assessed during pregnancy. Methods: A two-tiered approach was implemented: a ) In vitro high-throughput screening results from the ToxCast/Tox21 database, as informed by a thyroid Adverse Outcome Pathway network, were evaluated to select phenols/phthalates with activity on known and putative molecular initiating events in the thyroid pathway; and b ) Adjusted linear regressions were used to study associations between filtered compounds and serum thyroid hormones measured in 437 pregnant women recruited in Grenoble area (France) between 2014 and 2017. Phenol/phthalate metabolites were measured in repeated spot urine sample pools (median: 21 samples/women). Results: The ToxCast/Tox21 screening reduced the chemical set from 16 to 13 and the associated number of statistical comparisons by 19%. Parabens were negatively associated with free triiodothyronine (T3) and the T3/T4 (total thyroxine) ratio. Monobenzyl phthalate was positively associated with total T4 and negatively with the T3/T4 ratio. Effect modification by iodine status was detected for several compounds (among them ΣDEHP and mono- n -butyl phthalate) that were associated with some hormones among women with normal iodine levels. Conclusion: For these chemicals, screening for compounds with an increased likelihood for thyroid-related effects and relying on repeated urine samples to assess exposures improved the overall performance of multichemical analyses of thyroid disruption. This approach may improve future evaluations of human data for the thyroid pathway with implication for fetal health and may serve as a model for evaluating other toxicity outcomes. https://doi.org/10.1289/EHP10239. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: Environmental health perspectives, 2022 (prima pubblicazione 2022-11-09). Identificativi: PMID 36350136 · PMCID PMC9645207 · DOI 10.1289/ehp10239. Descrittori MeSH principali: Iodine; Phthalic Acids; Adverse Outcome Pathways. Pagina: https://europepmc.org/article/MED/36350136 — https://doi.org/10.1289/ehp10239. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-15T16:49:17.605Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.